US releases preliminary list of $2 generic drugs for Medicare recipients
Biogen fills in some of the blanks on its trial of a high-dose version of Spinraza
Roche CEO: breast cancer pill could enter $12 bln market if trials succeed
Sage continues downslide as Alzheimer’s study fails
*please scroll down for all the latest news*
Check open job listings in your area
Click here to stay updated on CP happenings
learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud
*please scroll down for all the latest news* image: 
Original Article
